Cupid Limited has kicked off FY27 on a strong note, reporting a 194% year-on-year jump in net profit to Rs. 44.15 crore for the quarter ended June 30, 2026, as operating income surged 159% to Rs. 154.72 crore.
The company, which operates across consumer wellness, personal care and healthcare markets, also raised its full-year FY27 guidance, now targeting revenue of Rs. 725 crore-Rs. 750 crore and net profit of Rs. 210 crore-Rs. 225 crore.
Cupid's consolidated total income rose 142% year-on-year to Rs. 156.98 crore in Q1 FY27, compared with Rs. 64.75 crore in the year-ago quarter. Operating income climbed from Rs. 59.80 crore to Rs. 154.72 crore.
Profitability improved sharply, with EBITDA jumping 265% YoY to Rs. 60.06 crore, while the EBITDA margin expanded to 39% from 28%, a gain of 1,127 basis points. Profit before tax rose 206% to Rs. 59.92 crore.
The company also delivered sequential growth, with operating income rising 29% from Rs. 119.96 crore in Q4 FY26, while net profit increased 22% from Rs. 36.26 crore.
Cupid said growth during the quarter was supported by continued momentum across its international B2B healthcare operations and domestic Consumer Healthcare and FMCG businesses.
Its international B2B healthcare business continued to see strong demand from PFSCM, WHO/UNFPA, institutional procurement programmes, government tenders and private export markets, giving the company greater order visibility and a healthy revenue pipeline.
The company said the rise in operating income reflects increasing contributions from its core businesses and strengthens the quality and sustainability of its earnings growth.
Cupid also expects sizeable orders for its IVD Kits portfolio from multiple state governments in India. International opportunities are also expanding following the receipt of CE certifications, with several deals reportedly in the final stages of the award process.
The company has implemented a minimum 10% price increase across its export portfolio, which is expected to support higher realisations and further margin expansion.
A favourable USD/INR environment has also aided export realisations, while the company said prudent hedging of currency exposure related to its international investments is helping mitigate foreign exchange risks.
With a strong order book, an expanding Consumer Healthcare and FMCG portfolio, healthy international B2B demand and expectations of a robust second half, Cupid has upgraded its FY27 outlook.
The company now expects Rs. 725 crore-Rs. 750 crore in revenue and Rs. 210 crore-Rs. 225 crore in net profit for FY27, signalling increased confidence in its growth trajectory.
